Zimmer Biomet lowers earnings outlook but increases revenue growth forecast

From Nasdaq: 2025-05-05 06:52:00

Zimmer Biomet Holdings Inc. announced a trimmed adjusted earnings guidance for 2025 due to the Paragon 28, Inc. acquisition and currency expectations. The company raised its annual revenue growth outlook to include Paragon 28, currency, and tariff proposals impact. Adjusted earnings for 2025 are now projected between $7.90 to $8.10 per share with revenue growth of 5.7 to 8.2 percent. Previously, earnings were expected to be $8.15 to $8.35 per share with revenue growth of 1.0 to 3.5 percent. Analysts predict earnings of $8.21 per share on revenue growth of 3.03 percent to $7.91 billion for the year.



Read more at Nasdaq: Zimmer Biomet Trims FY25 Adj. EPS Outlook, But Boosts Revenue Growth – Update